Lissencephaly 10 is a rare genetic brain-development condition. It affects how the brain’s surface folds and can lead to developmental delays and seizures. Signs often appear in infancy and the condition is lifelong. Care focuses on seizure control, nutrition, therapies, and supportive care, and not everyone will have the same experience. The outlook varies by severity, and pediatric neurology teams guide care for children with Lissencephaly 10.
Overview
Lissencephaly 10Symptoms
Early signs of Lissencephaly 10 often appear in infancy. They include seizures, very delayed development, low muscle tone, feeding or swallowing trouble, and poor balance or coordination; some babies have breathing difficulties and a smaller-than-expected head size.
Outlook and prognosis
Many living with Lissencephaly 10 face significant developmental challenges, seizures, and feeding or breathing difficulties that start in infancy. Outcomes vary by gene change and symptom severity; some children reach limited milestones, while others have more complex medical needs. Close neurologic care, nutrition support, and respiratory monitoring can improve comfort and reduce complications.
Causes and risk factors
Lissencephaly 10 results from a pathogenic change in a single brain-development gene, usually arising de novo, or rarely inherited. Risk increases with a parent carrying a variant, consanguinity, or advanced paternal age. Environmental or lifestyle factors do not cause it.
Genetic influences
Genetics are central in Lissencephaly 10, which is caused by pathogenic changes in the EML1 gene affecting brain development. Most cases arise from new (de novo) variants, though rare families show inherited patterns. Genetic testing confirms diagnosis, guides prognosis, and informs recurrence risk.
Diagnosis
Doctors suspect Lissencephaly 10 from clinical features on exam and distinctive brain imaging, typically MRI. Genetic diagnosis of Lissencephaly 10 is confirmed by sequencing the associated gene and, when needed, targeted panels or exome testing.
Treatment and drugs
Treatment for Lissencephaly 10 focuses on comfort, seizure control, and supporting breathing, feeding, and development. Care often includes anti‑seizure medicines, nutrition support or feeding tubes, respiratory care, and physical, occupational, and speech therapies. Coordinated follow‑up with neurology, genetics, pulmonology, gastroenterology, and rehabilitation helps adapt care as needs change.
Symptoms
Families often first notice feeding challenges, weak muscle tone, or unusual movements in the first months of life. Early features of Lissencephaly 10 can include seizures, developmental delays, and trouble with head growth. Features vary from person to person and can change over time. Because Lissencephaly 10 affects how the brain formed before birth, the signs tend to appear in infancy and continue to impact daily skills.
Seizures can start in the first months, including infantile spasms. They may look like brief stiffening, jerks, or clusters of head drops. Medicines and specialized diets can help reduce episodes.
Children with Lissencephaly 10 often reach milestones later than expected. Learning and communication can also be affected. Therapies can support progress over time.
Babies may feel floppy and have trouble holding up their head. This low tone can make feeding and movement harder. Over time, tone may shift toward stiffness in some areas.
Weak suck, poor coordination, or swallowing problems can lead to slow weight gain. Some children with Lissencephaly 10 need thickened liquids or tube feeding to stay safe and nourished. A speech-language therapist can guide safe feeding strategies.
How people usually first notice Lissencephaly 10?
Parents and doctors often first notice the first signs of lissencephaly 10 in the first weeks to months of life, when a baby has poor muscle tone (feels “floppy”), feeding difficulties, or seizures that can begin early and be hard to control. Head size may be smaller than expected, and developmental milestones like holding up the head, rolling, or visual tracking may be delayed. Brain imaging, usually an MRI prompted by seizures or delays, shows the characteristic smooth or simplified brain surface that confirms how lissencephaly 10 is first noticed.
Types of Lissencephaly 10
People with Lissencephaly 10 can have different clinical variants, and these differences often shape day-to-day needs like feeding, movement, and seizure management. Broadly, symptoms are grouped into patterns based on the gene involved and how much the brain’s surface is affected. Not everyone will experience every type. When people search for types of Lissencephaly 10, they’re usually asking about these recognized clinical variants and how symptoms differ among them.
Classic lissencephaly
This variant shows a very smooth brain surface with few or no folds, leading to early-onset seizures and significant developmental delays. Feeding difficulties, low muscle tone, and breathing challenges are common. Many need full-time supportive care.
Subcortical band heterotopia
In this form, an extra “band” of misplaced brain cells sits beneath a more folded outer surface, often causing seizures and learning differences. Motor skills may be better preserved than in classic lissencephaly. Symptom intensity can range from mild to severe.
Posterior-predominant pattern
The back parts of the brain are more affected than the front, which can change vision, coordination, and seizure types. Language and social engagement may be relatively stronger than motor control. Some children show better hand use than walking balance.
Anterior-predominant pattern
The front parts of the brain are more affected, which can more strongly impact planning, movement initiation, and behavior regulation. Seizures still occur but may start later than in diffuse forms. Therapies often target communication and executive skills.
Mild cortical malformation
This milder end of the spectrum shows partial smoothing with preserved folds in some regions and may present with later-onset seizures or learning challenges. Motor milestones can be delayed but sometimes improve with therapy. School support and anti-seizure care are common needs.
What genetics can tell you about symptoms
Some people with lissencephaly 10 develop severe seizures, low muscle tone, and delayed milestones because pathogenic variants in the EOMES/TBR2 gene disrupt early brain layering, leading to smoother, simplified cortical folds. Changes in this gene can also affect head size, coordination, and learning.
Causes and risk factors
Lissencephaly 10 is caused by a change in a single gene that disrupts how brain cells move and layer before birth.
This gene change can occur as a new change in the child, or it can be inherited from a parent who carries it.
The main risk factors for Lissencephaly 10 are genetic, such as having a parent with the same gene change.
Environmental exposures and lifestyle do not cause this subtype, but good prenatal care supports overall fetal brain health.
Doctors distinguish between risk factors you can change and those you can’t.
Environmental and biological risk factors
Lissencephaly 10 develops before birth, so the most relevant risks are present around conception and during early pregnancy. Understanding environmental and biological risk factors for Lissencephaly 10 during pregnancy can help families and care teams plan ahead. Doctors often group risks into internal (biological) and external (environmental). Most pregnancies with these exposures still result in babies without this condition.
Older paternal age is linked to a slightly higher chance of brain-development conditions that begin before birth, including rare forms like Lissencephaly 10. The added risk rises gradually with age, and most older fathers still have healthy children.
Pregnancy at an older maternal age carries a modestly higher chance of early developmental differences in the fetus. Close prenatal monitoring can help track brain growth.
High-dose ionizing radiation in early pregnancy can interfere with how the fetal brain forms its layers. While not proven to cause Lissencephaly 10 specifically, limiting avoidable radiation during weeks 8–16 is standard practice.
Prenatal exposure to metals like lead or mercury can harm developing brain tissue. A direct link to this condition is not established, but minimizing exposure helps protect fetal brain development.
Genetic risk factors
Lissencephaly 10 is linked to changes in a gene that guides early brain development. Most cases happen because a new change arises for the first time, while some are inherited within families. Carrying a genetic change doesn’t guarantee the condition will appear. Genetic testing can confirm the cause and is often considered when early symptoms of Lissencephaly 10 raise concern.
CEP85L gene changes: Changes in the CEP85L gene are the known genetic cause of Lissencephaly 10. These changes disrupt how brain cells migrate before birth. Genetic testing can identify the specific variant.
Autosomal dominant inheritance: Lissencephaly 10 usually follows an autosomal dominant pattern. If a parent carries the CEP85L change, each child has a 50% chance to inherit it. Severity can differ between family members.
De novo variants: Many people have a CEP85L change that occurred for the first time in the egg or sperm. When this happens, the chance of it happening again in another pregnancy is generally low but not zero. A genetics professional can clarify recurrence risk for your family.
Parental mosaicism: A parent can carry the CEP85L change in a portion of their reproductive cells but test negative in blood. This mosaic pattern can increase the chance of recurrence despite normal parental testing. More detailed testing may be discussed in these situations.
Variable expressivity: People with the same CEP85L change can have different features and severity. Risk is not destiny—it varies widely between individuals. Some adults with the variant may have mild or subtle findings.
Family history: Having a close relative with a confirmed CEP85L variant increases genetic risk for Lissencephaly 10. Relatives may consider testing to see whether they carry the same change. This can support planning and early monitoring.
Lifestyle risk factors
Lifestyle habits do not cause Lissencephaly 10, but they can influence symptom control, comfort, and the risk of complications. Understanding how lifestyle affects Lissencephaly 10 helps caregivers tailor daily routines that support breathing, feeding, mobility, and seizure control. While there are no lifestyle risk factors for Lissencephaly 10 that determine whether someone has it, day-to-day choices can change outcomes. Small, consistent habits often add up to fewer hospitalizations and more stable health.
Adequate calories and safe feeding techniques help maintain growth and reduce aspiration risk. Thickened feeds or slow pacing may lessen reflux that can worsen breathing and irritability.
Consistent medication timing and trigger tracking improve seizure control. Avoiding missed doses and promptly addressing illness or fever can prevent clusters.
Sleep deprivation can increase seizure frequency and daytime dysregulation. A steady routine and soothing environment may lengthen sleep and reduce nighttime events.
Supported seating and regular stretching can limit contractures and scoliosis that impair breathing and feeding. Side-lying or upright positions after meals may reduce reflux and aspiration.
Risk prevention
Lissencephaly 10 starts before birth and, in most families, can’t be prevented once conception occurs. Prevention here focuses on understanding family risk and reducing complications through early, proactive care. Prevention is about lowering risk, not eliminating it completely. Planning ahead and building a care plan early often make the biggest difference over time.
A genetics professional can explain how Lissencephaly 10 may run in your family and what the recurrence risk could be. They can outline options like carrier testing, prenatal tests, or IVF with embryo testing.
If Lissencephaly 10 is suspected, testing an affected child (or stored DNA) to find the exact gene change can guide future pregnancies. Knowing the familial variant opens the door to targeted testing.
Some families choose IVF with embryo testing (PGT-M) to transfer an embryo without the known familial variant. This approach lowers the chance of Lissencephaly 10 in a future child.
If the familial change is known, chorionic villus sampling or amniocentesis can check the fetus; detailed ultrasound and fetal MRI can add structural information. Talking through prenatal testing for Lissencephaly 10 helps align choices with your values.
Transmission
Lissencephaly 10 is not contagious; it can’t be caught or spread between people. It happens because of a change in a gene that affects brain development before birth.
In many cases, the gene change is new in the child (a de novo variant); in others, it can be passed down from a parent, and how Lissencephaly 10 is inherited depends on the exact gene change in the family. This may involve a single altered copy from one parent (dominant), a copy from each parent who are carriers (recessive), or, less often, an X‑linked pattern; a genetics team can explain the genetic transmission of Lissencephaly 10 and discuss recurrence risk and testing options.
When to test your genes
Consider genetic testing if a clinician suspects lissencephaly on prenatal or postnatal brain imaging, if a baby shows severe developmental delay or seizures without a clear cause, or if there’s a family history of lissencephaly or early infant loss. Testing guides diagnosis, prognosis, recurrence risk, and tailored care.
Diagnosis
Lissencephaly 10 is usually identified because of early developmental delays, seizures, or low muscle tone that prompt a closer look at brain development. Getting a diagnosis is often a turning point toward answers and support. Doctors focus on recognizable clinical features and detailed brain imaging, then confirm the cause with genetic tests. In many cases, the genetic diagnosis of Lissencephaly 10 clarifies care plans and helps families understand future risks.
Neurology and developmental exams look for low muscle tone, feeding challenges, seizures, and delayed milestones. These findings point doctors toward conditions that affect how the brain formed before birth.
Detailed imaging shows fewer or smoother brain folds and a thicker outer layer. In Lissencephaly 10, doctors may also see a “ribbon-like” band of misplaced brain tissue just under the surface, which helps distinguish it from other types.
A gene panel for lissencephaly-related genes or whole-exome testing can identify changes in genes known to cause Lissencephaly 10. Confirming the exact gene change establishes the diagnosis and can guide treatment planning and family counseling.
An EEG records brain wave patterns to check for seizure activity and types. Results help tailor anti-seizure treatment, though EEG alone cannot confirm Lissencephaly 10.
Stages of Lissencephaly 10
Lissencephaly 10 does not have defined progression stages. It’s a difference in brain development that begins before birth, so the brain pattern on imaging stays relatively stable, even though seizures, feeding, and developmental needs may change with age. Early symptoms of Lissencephaly 10 may include low muscle tone, feeding challenges, or seizures in infancy; diagnosis typically uses brain MRI, EEG to assess seizures, and genetic testing to identify the exact subtype. Different tests may be suggested to help piece together what’s going on, and regular follow-up tracks growth, movement, and seizure control over time.
Outlook and prognosis
Looking ahead can feel daunting, but many families focus on what each day brings—feeding, comfort, and helping a child engage with sounds and touch. The outlook for people with Lissencephaly 10 varies with how extensive the brain changes are, the severity of seizures, and whether breathing or feeding issues are present. Doctors call this the prognosis—a medical word for likely outcomes. Some children with Lissencephaly 10 have frequent, hard‑to‑control seizures and significant developmental delays; others may achieve small but meaningful milestones like improved head control or responding to a parent’s voice.
In medical terms, the long-term outlook is often shaped by both genetics and lifestyle. Early symptoms of Lissencephaly 10 that predict a more complex course include feeding difficulties, aspiration, repeated chest infections, and early, refractory seizures. When these issues are intense, life expectancy can be shortened, sometimes into childhood, often due to pneumonia, severe seizures, or complications from poor swallowing. When seizures respond better to treatment and breathing and nutrition are well supported, some children live into adolescence and, in milder cases, adulthood.
Many people find that symptoms are most challenging in the first years, when seizures and feeding problems are being stabilized. With coordinated care—neurology, nutrition, respiratory support, and therapies—many families create a steadier routine and reduce hospital stays. Support from friends and family can help shoulder daily tasks and sustain emotional wellbeing over the long run. Talk with your doctor about what your personal outlook might look like, including ways to prevent chest infections, manage seizures, and plan for nutrition and mobility needs.
Long-term effects
Lissencephaly 10 is present from birth, so the long-term picture centers on ongoing developmental and neurological challenges rather than short-term symptoms. Long-term effects vary widely, and the course depends on how much the brain’s surface and wiring were affected before birth. Many children need significant support with movement, feeding, and communication, and these needs often continue into adulthood. Seizures and breathing complications are common drivers of the overall outlook.
Delays in sitting, standing, and communication tend to be marked and ongoing. While early symptoms of Lissencephaly 10 may show up in infancy, the long-term pattern usually includes limited speech and learning. Many continue to rely on others for daily activities.
Seizures often begin in infancy or early childhood and can be difficult to control over time. The seizure pattern may change across the years, and episodes can affect alertness and development.
Low or high muscle tone, poor coordination, and stiffness can limit mobility. Many people with Lissencephaly 10 use wheelchairs or need assistance for transfers and positioning.
Difficulty swallowing and reflux are common and can lead to poor weight gain. Over the long term, some people with Lissencephaly 10 need alternative ways to meet nutrition safely.
How is it to live with Lissencephaly 10?
Daily life with lissencephaly 10 often centers on supporting basic needs and comfort while navigating significant developmental challenges. Many children have low muscle tone, feeding difficulties, seizures, and limited communication, so families build routines around therapy appointments, safe feeding strategies, seizure action plans, and adaptive equipment for positioning and mobility. Caregivers and siblings may feel a mix of love, grief, fatigue, and pride, and they often rely on a team—neurology, genetics, therapy, palliative care, and community supports—to share the load and celebrate small milestones. While medical needs can be intensive, structured care, respite, and connection with other families can make daily life more manageable and meaningful.
Treatment and drugs
Treatment for Lissencephaly 10 focuses on easing symptoms, supporting development, and preventing complications, since there’s currently no cure for the underlying brain-formation changes. Care often includes anti-seizure medicines, therapies to support feeding and breathing, physical and occupational therapy to improve comfort and mobility, and speech/communication support; a nutrition plan and reflux management can help with growth and aspiration risk. Doctors sometimes recommend a combination of lifestyle changes and drugs, and care is usually coordinated by a pediatric neurologist with input from respiratory, gastrointestinal, rehabilitation, and palliative care teams. If seizures are hard to control, options may include trying different anti-seizure drugs, ketogenic diet, or device-based therapies, depending on individual needs and safety. Supportive care can make a real difference in how you feel day to day, so keep track of symptoms and discuss goals with your care team to adjust treatment as your child grows.
Non-drug treatment
Care for Lissencephaly 10 focuses on building skills, easing daily care, and preventing complications. Some families first notice early symptoms of Lissencephaly 10, like weak muscle tone or feeding trouble, and therapy starts soon after diagnosis. Alongside medicines, non-drug therapies often form the backbone of day-to-day support. Plans are individualized and adjusted as children grow.
Coordinated services in infancy and toddler years can boost development during a key window. Teams help set goals and coach families on daily activities.
Guided exercises help improve head control, balance, and mobility. Stretching and positioning can reduce stiffness and prevent joint tightness.
Practice with reaching, grasping, and self-care builds everyday function. Therapists adapt toys and routines so activities are doable and safe.
Support targets swallowing safety, feeding endurance, and early communication. Strategies may include pacing feeds, texture changes, and alternative communication.
Your genes may have an impact on how drugs work for you
Some medicines used for seizures and muscle tone in people with Lissencephaly 10 can work differently depending on genes that affect drug processing or brain receptors. Genetic testing may guide dosing and help avoid side effects, but clinical response still leads decisions.
Pharmacological treatments
There isn’t a drug that reverses the brain changes in Lissencephaly 10, so treatment focuses on easing day-to-day symptoms like seizures, tight muscles, reflux, and sleep problems. Drugs that target symptoms directly are called symptomatic treatments. Because early symptoms of lissencephaly 10 often include seizures, anti-seizure therapies are usually central and adjusted over time. Plans are individualized and reviewed often to balance benefits with side effects.
Levetiracetam, valproate, lamotrigine, topiramate, and oxcarbazepine are common options to reduce seizures in Lissencephaly 10. Dosing may be increased or lowered gradually to find the lowest effective dose. Blood tests may be used for safety with some drugs like valproate.
Diazepam rectal gel and midazolam nasal spray can stop a prolonged seizure at home or school. Your care team can teach when and how to use them safely. Keep these medicines with the child and ensure caregivers know the plan.
If spasms occur, ACTH injections, high-dose prednisolone, or vigabatrin may be used. These require close monitoring for side effects and regular follow-up. Early treatment may improve seizure control in Lissencephaly 10.
Baclofen, diazepam, or tizanidine can relax tight muscles that cause stiffness or pain. Botulinum toxin injections may help specific tight muscle groups. These treatments can improve comfort and ease positioning and care.
Genetic influences
Lissencephaly 10 is linked to a change in a single gene that helps guide how brain cells move and layer during early pregnancy. This gene change may be inherited from a parent or may appear for the first time in a child; the pattern can differ between families. DNA testing can sometimes identify these changes. In practice, genetic testing for Lissencephaly 10 can confirm the gene involved and help tailor care and planning for your family. Pinpointing the exact change can clarify the chance of Lissencephaly 10 recurring in future pregnancies and whether parents or siblings could carry it. Severity varies, so even when the same gene is involved, features and outcomes can differ, and a result does not predict every detail.
Is Lissencephaly 10 genetic?
Genetics are central in Lissencephaly 10, which is caused by pathogenic changes in the EML1 gene affecting brain development. Most cases arise from new (de novo) variants, though rare families show inherited patterns. Genetic testing confirms diagnosis, guides prognosis, and informs recurrence risk.
Pharmacogenetics—how genetics influence drug effects
For Lissencephaly 10, medicines mainly address symptoms such as seizures, muscle stiffness, and feeding or sleep issues; there isn’t a drug that changes the underlying brain development. Alongside medical history and seizure type, genetic testing can sometimes identify how your body handles certain anti‑seizure medicines, which can guide safer starting doses or help avoid serious side effects. For example, certain tissue types in the immune system (like HLA‑B*15:02, more common in parts of Asia) greatly increase the risk of severe skin reactions with carbamazepine or oxcarbazepine, so doctors may choose different drugs. Differences in liver enzymes can also affect how quickly medicines like phenytoin or clobazam are broken down, meaning some children need lower doses to prevent dizziness or extra sleepiness. In addition, rare changes in the POLG gene raise the risk of dangerous liver problems with valproate, so teams may avoid it or test first if there are warning signs. When weighing medication options for Lissencephaly 10, genes are just part of the picture; age, other medicines, nutrition, and overall health also shape which drug and dose are likely to work best.
Interactions with other conditions
Chest infections, reflux, and feeding problems often shape day-to-day care more than anything else, because trouble swallowing can lead to aspiration and repeated pneumonias. Doctors call it a “comorbidity” when two conditions occur together. Epilepsy is very common in Lissencephaly 10 and may overlap with infantile spasms; seizure medicines can interact with breathing issues, increase sleepiness or constipation, and sometimes make feeding more difficult, so coordinated care matters. Reflux can worsen sleep and raise aspiration risk, which in turn may trigger more seizures or hospital visits, and muscle tone differences can resemble cerebral palsy, bringing risks of scoliosis and hip problems. Limited mobility and certain anticonvulsants can reduce bone strength, increasing fracture risk, while chronic constipation and urinary infections may also occur alongside neurological symptoms. Early symptoms of Lissencephaly 10 can blend with signs of other developmental disorders, so working with neurology, gastroenterology, respiratory, nutrition, and therapy teams helps align treatments and avoid one condition aggravating another.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described babies who struggled to feed, cried weakly, and didn’t meet early milestones, long before brain imaging could explain why. Families and midwives noticed when a newborn’s head seemed smaller than expected or when seizures started in the first weeks of life. For many, this meant long nights watching over a child whose development didn’t follow the usual path, with few answers and even fewer treatments.
From early theories to modern research, the story of lissencephaly has moved from bedside observation to understanding the brain’s growth before birth. The word itself means “smooth brain,” a clue from the surface appearance seen at autopsy in the mid-20th century. Early reports focused on the lack of brain folds and on severe developmental delay and epilepsy. As brain scans like CT and then MRI became available, doctors could see the pattern in living children and sort lissencephaly into related types. This shift revealed that not all cases were the same; some had a nearly smooth surface, while others had fewer or broader folds.
Advances in genetics then changed the picture again. Researchers linked certain patterns on MRI to changes in specific genes that guide how brain cells move into place during pregnancy. Over time, different forms were tied to different genes, which helped explain why some children had additional features such as very small head size, muscle stiffness, or feeding difficulties. It also clarified why lissencephaly can appear on its own in a child with no family history or, less often, recur in families due to inherited changes.
Lissencephaly 10 refers to one of these genetic forms, connected to changes in a gene called CDK5. It was recognized more recently as genetic testing became more detailed and widely available. Before that, many children with what we now call lissencephaly 10 would have been grouped under broader labels. The CDK5 gene helps time the steps of early brain development; when it doesn’t work as expected, the brain’s layering and folding can be affected in a particular pattern. Identifying this form has helped clinicians give families clearer information about what to expect and how likely the condition is to happen again in future pregnancies.
In recent decades, knowledge has built on a long tradition of observation. Detailed MRI criteria, improved seizure management, and early therapies have reshaped care, even as the core challenges remain. While there is no cure, the history of lissencephaly 10 shows steady progress: from recognizing early symptoms of lissencephaly to pinpointing the gene involved, and from uncertainty to more tailored support. Knowing the condition’s history helps explain why today’s care includes genetics, neurology, and developmental services working together.